Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-29

Clinical Trial Update: Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study [Phase 3]

View source ↗

Summary

Phase III clinical trial examining Nile Tilapia fish skin xenograft for burn treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nile Tilapia fish skin xenograft

Snippet

Sponsor: Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | Conditions: Burns | Phase 3 | Status: COMPLETED